In Brief: FDA restructuring
This article was originally published in The Tan Sheet
Executive Summary
FDA restructuring: Senate Labor & Human Resources Committee hearing on proposals to revise and restructure the operations of FDA has been rescheduled to March 19 from March 18 ("The Tan Sheet" March 3, p. 23). The hearing is expected to address renewal of the Prescription Drug User Fee Act, among other issues. Sen. James Jeffords (R-Vt.) is slated to commence the hearing at 9:30 a.m. in the Dirksen Building, Room SD-430...